ZURICH (Reuters) - Roche Holding AG is aiming to launch at least six new products by the end of 2014 and is seeking to further boost its position in areas outside oncology, the Swiss drugmaker said ahead of its investor day. Roche, the world's largest maker of cancer drugs, is aiming to build up its strength in the therapeutic areas ...

BOSTON (Reuters) - Studying genes linked to breast cancer may someday lead to better treatments, but they do little to improve a doctor's ability to predict who is likely to develop a tumor, researchers reported on Wednesday. Their study in the New England Journal of Medicine found that testing for 10 errant bits of genetic code linked to breast cancer ...

Researchers launched a clinical study Wednesday to test new treatments for aggressive breast cancer in a rare alliance between the US government and five major drug companies. The new drugs may help boost survival rates for women diagnosed with this type of breast cancer which does not respond to the standard treatments, the Biomarkers Consortium said in a statement. The ...

WASHINGTON (Reuters) - Myriad Genetics' disputed patent on the BRCA1 breast cancer gene is "surprisingly broad" and could interfere with future research, three experts said on Tuesday. Their ongoing research indicates some other gene patents are similarly extensive, covering stretches of DNA that have nothing to do with the targeted genes, they reported in the journal Genomics. "We find that, through ...